Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2013 (2013), Article ID 727905, 10 pages
http://dx.doi.org/10.1155/2013/727905
Research Article

The Impact of Migrations on the Health Services for Rare Diseases in Europe: The Example of Haemoglobin Disorders

1Thalassaemia International Federation (TIF), 31 Ifigeneias Street, 2007 Strovolos, Nicosia, Cyprus
2European Network for Rare and Congenital Anaemias (ENERCA), 08036 Barcelona, Spain
3University of Barcelona, Hospital Clinic, Biological Diagnostic Centre, 08036 Barcelona, Spain
4Cyprus Institute of Biomedical Sciences (CIBS), Department of Occupational and Environmental Medicine, 2042 Nicosia, Cyprus
5Harvard School of Public Health, Department of Environmental Health, Environmental and Occupational Medicine and Epidemiology (EOME), Boston, MA 02115, USA

Received 28 December 2012; Accepted 21 January 2013

Academic Editors: Y. Al-Tonbary, M. A. Badr, A. El-Beshlawy, A. Mansour, and F. Tricta

Copyright © 2013 Michalis Angastiniotis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [15 citations]

The following is the list of published articles that have cited the current article.

  • Bing Li, Xiao-zhuang Zhang, Ai-hua Yin, Qing-guo Zhao, Li Wu, Yuan-zhu Ma, Ming-yong Luo, and Shou-yi Yu, “High prevalence of thalassemia in migrant populations in Guangdong Province, China,” Bmc Public Health, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Alice Albu, Carmen Gabriela Barbu, Lavinia Antonie, Florentina Vladareanu, and Simona Fica, “Risk Factors Associated With Hypogonadism in beta-Thalassemia Major Patients: Predictors for a Frequent Complication of a Rare Disease,” Postgraduate Medicine, vol. 126, no. 5, pp. 121–127, 2014. View at Publisher · View at Google Scholar
  • Michele Abi Saad, Anthony G. Haddad, Elie S. Alam, Sanaa Aoun, Pascale Maatouk, Najat Ajami, Therese Khairallah, Suzanne Koussa, Khaled M. Musallam, and Ali T. Taher, “Preventing Thalassemia in Lebanon: Successes and Challenges in a Developing Country,” Hemoglobin, pp. 1–4, 2014. View at Publisher · View at Google Scholar
  • Patricia Aguilar Martinez, Michael Angastiniotis, Androulla Eleftheriou, Beatrice Gulbis, Maria Del Mar Manu Pereira, Roumyana Petrova-Benedict, and Joan-Lluis Vives Corrons, “Haemoglobinopathies in Europe: health & migration policy perspectives,” Orphanet Journal of Rare Diseases, vol. 9, 2014. View at Publisher · View at Google Scholar
  • Frédéric B Piel, Andrew J Tatem, Zhuojie Huang, Sunetra Gupta, Thomas N Williams, and David J Weatherall, “Global migration and the changing distribution of sickle haemoglobin: a quantitative study of temporal trends between 1960 and 2000,” The Lancet Global Health, vol. 2, no. 2, pp. e80–e89, 2014. View at Publisher · View at Google Scholar
  • Antonio Amato, “Comment to the article "Prevention of B thalassemia in Northern Israel - a cost-benefit analysis" by Koren et al.,” Mediterranean Journal of Hematology and Infectious Diseases, vol. 6, no. 1, 2014. View at Publisher · View at Google Scholar
  • Annita Kolnagou, “Transition of Thalassaemia and Friedreich ataxia from fatal to chronic diseases,” World Journal of Methodology, vol. 4, no. 4, pp. 197, 2014. View at Publisher · View at Google Scholar
  • Giulia Breveglieri, Alessia Finotti, Monica Borgatti, and Roberto Gambari, “Recent patents and technology transfer for molecular diagnosis of β-thalassemia and other hemoglobinopathies,” Expert Opinion on Therapeutic Patents, pp. 1–24, 2015. View at Publisher · View at Google Scholar
  • Alexander E. Kentikelenis, and Amanda Shriwise, “International organizations and migrant health in Europe,” Public Health Reviews, vol. 37, no. 1, 2016. View at Publisher · View at Google Scholar
  • Giuseppina Barberio, and Giovanni Ivaldi, “Hemoglobinopathies in Italy. Part I: Clinical nosography and epidemiology,” Biochimica Clinica, vol. 40, no. 2, pp. 78–95, 2016. View at Publisher · View at Google Scholar
  • Kamal A. Kadhim, Kadhim H. Baldawi, and Faris H. Lami, “Prevalence, Incidence, Trend, and Complications of Thalassemia in Iraq,” Hemoglobin, pp. 1–5, 2017. View at Publisher · View at Google Scholar
  • Said Yousuf Mohamed, “Thalassemia Major: Transfusion and Chelation or Transplantation,” Hematology/Oncology and Stem Cell Therapy, 2017. View at Publisher · View at Google Scholar
  • Paolo Gorello, Francesco Arcioni, Antonietta Palmieri, Ylenia Barbanera, Laura Ceccuzzi, Cecilia Adami, Mauro Marchesi, Antonella Angius, Olivia Minelli, Marina Onorato, Antonio Piga, Maurizio Caniglia, Cristina Mecucci, and Antonella Roetto, “The Molecular Spectrum of β- and α-Thalassemia Mutations in Non-Endemic Umbria, Central Italy,” Hemoglobin, vol. 40, no. 6, pp. 371–376, 2017. View at Publisher · View at Google Scholar
  • Mariachiara Lodi, Elena Bigi, Giovanni Palazzi, Lara Vecchi, Riccardo Morandi, Monica Setti, Silvana Borsari, Giuliano Bergonzini, Lorenzo Iughetti, and Donatella Venturelli, “Universal Screening Program in Pregnant Women and Newborns at-Risk for Sickle Cell Disease: First Report from Northern Italy,” Hemoglobin, pp. 1–4, 2017. View at Publisher · View at Google Scholar
  • Giuseppina Barberio, Massimo Mogni, Massimo Maffei, Giovanni Ivaldi, and Livio Caberlotto, “Appropriatezza dei percorsi diagnostici per le emoglobinopatie: il caso Hb Hekinan,” La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine, 2018. View at Publisher · View at Google Scholar